Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02400580 · ClinicalTrials.gov registry record · Phase 4

IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy

A Phase 4 study of Pain, sponsored by University of Pittsburgh.

Completed
Registry status
Phase 4
Development phase
183
Enrollment target
1
Study location

NCT02400580: Completed Phase 4 study of Pain, sponsored by University of Pittsburgh.

NCT02400580 is a Phase 4 study of Pain that has completed, run by University of Pittsburgh. The registered enrollment target is 183 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02400580, a Phase 4 study of Pain, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
Phase 4
Development phase
183 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to quantify the change in post-operative pain scores and narcotic requirements in women receiving pre and post-operative IV acetaminophen compared to placebo in women undergoing laparoscopic hysterectomy.

Primary Outcome

The primary aim of this study is to compare overall post-surgical pain after hysterectomy as reported by the patients on a visual analog scale with a range of 0 to 10 where 0 is no pain at all and 10 is the worst pain that a person can imagine. Less pain is considered preferable to more pain. The theory is that patients who have intravenous acetaminophen will report less post-surgical pain.

Conditions Studied

Interventions

  • DRUG placebo
  • DRUG IV acetaminophen

Study Locations (1)

Pennsylvania

  • Magee Womens Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2015-02
Est. Completion 2016-09
Phase Phase 4
University of Pittsburgh

1,238 total trials

What the finished NCT02400580 record still lists

NCT02400580 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (40% lower).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT02400580 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02400580 about?

NCT02400580 is a clinical study titled "IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy". The objective of this study is to quantify the change in post-operative pain scores and narcotic requirements in women receiving pre and post-operative IV acetaminophen compared to placebo in women undergoing laparoscopic hysterectomy.

What is the current status of trial NCT02400580?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 183 participants. The study started on 2015-02. Estimated completion is 2016-09.

What conditions does trial NCT02400580 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT02400580?

The interventions under investigation include: placebo (DRUG), IV acetaminophen (DRUG).

Who is sponsoring clinical trial NCT02400580?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02400580 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02400580's enrollment target sits among peer trials

183 98th of 374 higher than 277 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03859297 · 183 participants · NA

    Mechanisms of Rumination Change in Adolescent Depression

  • NCT04270591 · 183 participants · Phase 1

    Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

  • NCT06764615 · 183 participants · Phase 2

    A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

  • NCT06872684 · 183 participants · NA

    Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02400580, the US trial registry maintained by the National Library of Medicine. NCT02400580 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.